An insightful interview about the CorNeat EverPatch with Dr. Gilad Litvin, our Co-Founder and Chief Medical Officer

CorNeat Vision's EverPatch utilizes EverMatrix™, a novel material technology able to integrate with surrounding tissue

“Until now, no one has found a way to seamlessly and permanently integrate synthetic material and literally embed it with surrounding tissue. I can’t emphasize enough the potential impact of this discovery on human health,” Dr. Gilad Litvin, Co-Founder & CMO at CorNeat Vision.

“This initial experience holds promise for a potential breakthrough in the treatment of corneal disease…”

Join us on our journey to change lives - this time in France!

CorNeat Vision was selected as one of two start-ups to watch in the MedTech Strategist's January issue

Two patients were implanted with the CorNeat KPro, our artificial cornea, in France and received extensive media coverage!

The presentation given by our Founder and CMO, Dr. Gilad Litvin, as part of the Innovators Grand Session at the 2021 ASCRS conference keeps making waves

Remote Surgeon Virtual Presence: A Novel Telementoring Method for Live Surgical Training

Almog Aley-Raz and Dr. Gilad Litvin, CorNeat Vision’s CEO & VP R&D and CMO, respectively, were interviewed by Globes newspaper for a special cornea project

The grant will support our clinical activities as well as the manufacturing and automation process which will enable us to reach the market with this cure!

Following the successful presentation of Dr. Gilad Litvin at the 2021 ASCRS conference

New Hope for the Corneally Blind Provides Definitive Protection from COVID-19 Transmission

CorNeat KPro: Ocular Implantation Study in Rabbits

The first-in-human (FIH) implantation of the CorNeat KPro is receiving a plethora of media traction

Canadian artificial cornea clinical trial enabled by a novel, remote, real-time 3D HD video training solution

CorNeat Vision is generating a lot of interest in the Arab world

Biomimetic Implant Provides Hope for Millions of Corneally Blind People with no Reliance on Donor Tissue

Tune in to this episode of The Joel Show and listen to an interview with Dr. Gilad Litvin and Almog Aley-Raz, speaking in greater detail about CorNeat Vision’s journey and where the company is at today

​Researchers at the Donald K. Johnson Eye Institute are on the leading edge of corneal transplant technology

Corneat Vision can help over 60 million blind eyes around the world

Innovative synthetic biology implants to be showcased at the 37th Congress of the ESCRS 2019 Paris

A nanotechnology-based solution to bring new hope to millions of blind and visually impaired